SCHEMBL23905699

SCHEMBL23905699

C=C(c1cc2c(c(-c3ccc(F)cc3)n1)OCC2(C)CO)C(F)(F)F

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CFTR P13569 1/20 0.32
CYP2C9 P11712 1/20 0.30
IDO1 P14902 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23905463 0.92 CFTR (0.32) CFTR
SCHEMBL23904857 0.91 CYP11B1 (0.32)
SCHEMBL23904802 0.88 CFTR (0.36) CFTRCYP2C9IDO1
SCHEMBL23905381 0.86 CFTR (0.33) CFTR
SCHEMBL24363605 0.83 CFTR (0.33) CFTR
SCHEMBL23904776 0.83 ADORA1 (0.31) CFTR
SCHEMBL23905341 0.83
SCHEMBL23904788 0.82 DPP4 (0.32) CFTRCYP2C9IDO1
SCHEMBL23905629 0.82
SCHEMBL31412420 0.82 GRM2 (0.34) CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed